Home » ADHD » ADHD Med Helps Women with Cognitive Challenges of Menopause
ADHD Med Helps Women with Cognitive Challenges of Menopause

ADHD Med Helps Women with Cognitive Challenges of Menopause

Results from a new study bring encouraging news to women experiencing mental problems that often accompany menopause.

Scientists have known that menopausal women may experience difficulty with time management, attention, organization, memory, and problem solving. These skills are often referred to as executive functions.

Researchers at the University of Pennsylvania discovered that lisdexamfetamine (LDX), a drug used to treat attention deficit hyperactivity disorder (ADHD), improved subjective and objective measures of cognitive decline commonly experienced in menopausal women.

Results of the study are published online in the journal Psychopharmacology.

“Reports of cognitive decline, particularly in executive functions, are widespread among menopausal women,” said lead author, C. Neill Epperson, M.D., professor of Psychiatry and Obstetrics and Gynecology.

“There are approximately 90 million post-menopausal women living in the US alone, and with the average age of onset occurring at 52, the great majority of those women will live in the postmenopausal state for at least one-third of their lives. Therefore, promoting healthy cognitive aging among menopausal women should be a major public health goal.”

The University of Pennsylvania led team administered a once-daily dose of LDX for four weeks to 32 healthy, non-ADHD-diagnosed women between the ages of 45 and 60 experiencing difficulties with executive functions as a result of mid-life onset menopause, and as measured using the Brown Attention Deficit Disorder Scale (BADDS). All participants served as their own controls by being randomly assigned to cross-over to a placebo for an additional four weeks.

Significant improvements were found with use of the drug as women receiving LDX experienced a 41 percent improvement in executive functions as compared to a 17 percent improvement when taking placebo medication.

There were also significant improvements in four out of the five subscales for women taking LDX: organization and motivation for work; attention and concentration; alertness, effort, and processing speed; and working memory and accessing recall.

While psychostimulants such as LDX are primarily marketed for the treatment of ADHD, they have been successful in treating cognitive complaints in some patients including postmenopausal women. They work by promoting the release of dopamine, which is impaired in ADHD and other disorders characterized by executive function problems.

“Although we observed that short-term use of LDX was well tolerated and effective in several subjective and objective areas, long-term studies of menopausal women receiving LDX are needed, similar to those conducted for ADHD patients,” said Epperson.

“It is also important for clinicians to confirm that a woman’s complaints of worsening memory are in the executive function domains, are temporally related to the transition to menopause, and are not indicative of some other pathological cognitive impairment before prescribing a trial of LDX.”

Source: University of Pennsylvania

ADHD Med Helps Women with Cognitive Challenges of Menopause

Rick Nauert PhD

Rick Nauert, PhDDr. Rick Nauert has over 25 years experience in clinical, administrative and academic healthcare. He is currently an associate professor for Rocky Mountain University of Health Professionals doctoral program in health promotion and wellness. Dr. Nauert began his career as a clinical physical therapist and served as a regional manager for a publicly traded multidisciplinary rehabilitation agency for 12 years. He has masters degrees in health-fitness management and healthcare administration and a doctoral degree from The University of Texas at Austin focused on health care informatics, health administration, health education and health policy. His research efforts included the area of telehealth with a specialty in disease management.

APA Reference
Nauert PhD, R. (2018). ADHD Med Helps Women with Cognitive Challenges of Menopause. Psych Central. Retrieved on November 30, 2020, from
Scientifically Reviewed
Last updated: 8 Aug 2018 (Originally: 12 Jun 2015)
Last reviewed: By a member of our scientific advisory board on 8 Aug 2018
Published on Psych All rights reserved.